US20200405321A1 - Cardiac implantable electronic device pocket compression apparatus and method of mitigating localized bleeding using same - Google Patents
Cardiac implantable electronic device pocket compression apparatus and method of mitigating localized bleeding using same Download PDFInfo
- Publication number
- US20200405321A1 US20200405321A1 US16/940,133 US202016940133A US2020405321A1 US 20200405321 A1 US20200405321 A1 US 20200405321A1 US 202016940133 A US202016940133 A US 202016940133A US 2020405321 A1 US2020405321 A1 US 2020405321A1
- Authority
- US
- United States
- Prior art keywords
- patient
- wrap
- block
- pressure
- medical device
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000000740 bleeding effect Effects 0.000 title claims abstract description 20
- 230000000116 mitigating effect Effects 0.000 title claims description 5
- 238000000034 method Methods 0.000 title abstract description 16
- 230000006835 compression Effects 0.000 title description 56
- 238000007906 compression Methods 0.000 title description 56
- 230000000747 cardiac effect Effects 0.000 title description 12
- 206010018852 Haematoma Diseases 0.000 claims abstract description 27
- 208000032843 Hemorrhage Diseases 0.000 claims abstract description 19
- 230000017531 blood circulation Effects 0.000 claims abstract description 16
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 10
- 208000034158 bleeding Diseases 0.000 claims abstract description 9
- 229920001084 poly(chloroprene) Polymers 0.000 claims description 4
- 238000003825 pressing Methods 0.000 claims description 4
- 239000013013 elastic material Substances 0.000 claims description 3
- 208000029154 Narrow face Diseases 0.000 claims description 2
- 239000011343 solid material Substances 0.000 claims 1
- 239000007787 solid Substances 0.000 abstract description 21
- 230000035876 healing Effects 0.000 abstract description 4
- 206010053567 Coagulopathies Diseases 0.000 abstract description 2
- 230000035602 clotting Effects 0.000 abstract description 2
- 239000000463 material Substances 0.000 description 16
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 6
- 239000000945 filler Substances 0.000 description 5
- 238000002513 implantation Methods 0.000 description 5
- 238000002560 therapeutic procedure Methods 0.000 description 5
- 230000008569 process Effects 0.000 description 4
- 239000004793 Polystyrene Substances 0.000 description 3
- 239000003146 anticoagulant agent Substances 0.000 description 3
- 230000010100 anticoagulation Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 229960000610 enoxaparin Drugs 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 229960002897 heparin Drugs 0.000 description 3
- 229920000669 heparin Polymers 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 229920002223 polystyrene Polymers 0.000 description 3
- 229920006328 Styrofoam Polymers 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 238000009125 cardiac resynchronization therapy Methods 0.000 description 2
- 229920006248 expandable polystyrene Polymers 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000008261 styrofoam Substances 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000012876 topography Methods 0.000 description 2
- 206010003658 Atrial Fibrillation Diseases 0.000 description 1
- 206010051055 Deep vein thrombosis Diseases 0.000 description 1
- 206010051077 Post procedural haemorrhage Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 206010047249 Venous thrombosis Diseases 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 210000005242 cardiac chamber Anatomy 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 210000003109 clavicle Anatomy 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 210000003195 fascia Anatomy 0.000 description 1
- 238000002594 fluoroscopy Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 208000031169 hemorrhagic disease Diseases 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 230000003447 ipsilateral effect Effects 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000002976 pectoralis muscle Anatomy 0.000 description 1
- 229920006327 polystyrene foam Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 210000001321 subclavian vein Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- PJVWKTKQMONHTI-UHFFFAOYSA-N warfarin Chemical compound OC=1C2=CC=CC=C2OC(=O)C=1C(CC(=O)C)C1=CC=CC=C1 PJVWKTKQMONHTI-UHFFFAOYSA-N 0.000 description 1
- 229960005080 warfarin Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/132—Tourniquets
- A61B17/1322—Tourniquets comprising a flexible encircling member
- A61B17/1325—Tourniquets comprising a flexible encircling member with means for applying local pressure
-
- A—HUMAN NECESSITIES
- A41—WEARING APPAREL
- A41D—OUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES
- A41D13/00—Professional, industrial or sporting protective garments, e.g. surgeons' gowns or garments protecting against blows or punches
- A41D13/12—Surgeons' or patients' gowns or dresses
- A41D13/1236—Patients' garments
- A41D13/1245—Patients' garments for the upper part of the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B2017/12004—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord for haemostasis, for prevention of bleeding
Definitions
- the invention generally relates to a medical apparatus and, more particularly, the invention relates to a treatment apparatus for use in connection with cardiac device implantations.
- pacing or defibrillator leads may be placed in the appropriate chambers of the heart. These leads may be secured to the fascia over the pectoralis muscle and the end of which may be usually plugged into the ports in the device generator. The portion of the leads and the generator may be placed in the pocket and closed in two or three layers of suture. Bleeders may be secured before closing the pocket. Sterile strips may be placed over the closed incision and allowed to heal over the next few days.
- pocket bleeding and hematoma formation may be seen in about 4.9% patients and the incidence may be higher in those receiving defibrillators compared to pacemakers.
- Pocket bleeding can prolong hospital stay in 1.5% of patients who receive these devices up to 2.5 days with about 0.5% requiring repeat hospitalization and close to 1% needing pocket revision and hematoma evacuation.
- the risk of post device bleeding and hematoma formation may be significantly higher (e.g., up to 12%-20%) in those patients who may be bridged with anticoagulants like heparin and enoxaparin. Even in those cases where warfarin is continued throughout the procedure, the risk of post procedural bleeding may be up to 2-6%. Often, large hematomas and subsequent evacuations lead to increased incidence of infection.
- a medical device for applying pressure to a localized area of patient's body includes a pliable wrap for wrapping around at least a portion of the patient, and a block of solid, non-inflatable material positioned between the wrap and the localized area of the patient.
- the wrap may be a vest for holding the block against the patient's torso, or a sleeve to hold the block against a patient's arm or a leg, to name but a few examples.
- the wrap includes an elastic material, such as neoprene for example, and may also include straps to adjust the pressure applied to a localized area on the patient by the block.
- the block is sized and shaped to apply pressure to the localized area of the patient, which pressure is sufficient to hinder but not completely prevent blood flow in the localized area of the patient's body.
- the block may have a wedge shape with a narrow face positioned to face the patient when the medical device is worn by the patient.
- Some embodiments include a sealable pouch in the medical device for securing the block in position, and some embodiments also include an absorbent sheath around the block within the pouch. Moreover, some embodiments include at least one filler member within the pouch to secure the location of the block within the pouch. Other embodiments secure the block with one or more straps, or a hook-and-loop fastener such as Velcro.
- a method of mitigating pocket bleeding and hematoma formation in a patient locates a localized torso area of the patient that may be subject to bleeding and/or hematoma formation.
- the localized torso area is at least in part covered by a bandage and/or dressing.
- the method provides a pliable wrap having a non-inflatable solid block coupled with the wrap, and then secures the pliable wrap around the torso of the patient to align the solid block with the located localized torso area.
- the solid block is secured between at least a portion of the wrap and the bandage and/or dressing, at least in part covering the localized torso area.
- the wrap is secured to cause the wrap to apply a force, to the solid block, that produces a corresponding pressure on the localized torso area.
- the force applied to the solid block is high enough to cause the pressure to hinder blood flow to the localized torso area to promote clotting at the localized torso area.
- the force applied to the solid block is low enough to cause the pressure to permit blood flow to the localized torso area to promote healing.
- FIG. 1 schematically illustrates a front view of the outer surface of a compression vest in a detached configuration in accordance with illustrative embodiments
- FIG. 2 schematically illustrates a rear view of the inner surface of a compression vest in a detached configuration in accordance with illustrative embodiments
- FIG. 3A schematically illustrates details of a fabric for a compression vest in accordance with illustrative embodiments
- FIG. 3B schematically illustrates a compression block urged towards a patient's body by a garment
- FIG. 3C schematically illustrates pressure gradient within a patient
- FIG. 4 schematically illustrates a front view in an attached configuration in accordance with illustrative embodiments
- FIG. 5 schematically shows a rear view in an attached configuration in accordance with illustrative embodiments
- FIGS. 6A-6B schematically illustrate an incision on the chest of a patient
- FIGS. 6C-6D schematically illustrate a front view in an attached configuration on a patient and a rear view in an attached configuration on a patient, respectively, in accordance with illustrative embodiments;
- FIGS. 7A-7D schematically illustrate embodiments of compression blocks for use with a compression garment in accordance with illustrative embodiments
- FIGS. 7E-7F schematically illustrate cross sections of embodiments of compression blocks
- FIG. 7G schematically illustrates an embodiment of a compression block in a sheath
- FIG. 8 schematically illustrates an embodiment of a compression sleeve
- FIG. 9 is a flow chart illustrating a method of using a garment.
- Illustrative embodiments mitigate pocket bleeding and hematoma formation in a patient by providing constant, adjustable pressure to a localized area of the patient's body.
- a mechanical, noninvasive garment has adjustable levels of compression to treat and/or substantially reduce the likelihood of hematomas from cardiac devices, such as pacemakers, defibrillators, loop recorders, and pressure monitoring systems placed underneath the skin in the human chest/torso.
- the garment may be formed as a single unit with straps, and includes a compression block in a pouch of the garment. During use, the block applies specific pressure to a targeted area of the patient.
- the garment may be worn in a similar manner to a jacket, i.e., over the shoulder that is closest to the cardiac device.
- a first shoulder strap can be adjusted for appropriate contact, while a second strap (e.g., around the chest) may be adjusted to selectively apply pressure to the block, consequently applying pressure to the targeted area.
- a second strap e.g., around the chest
- Illustrative embodiments may be used over a device pocket (formed in a patient's body), which may have a hematoma, or may be used in a prophylactic fashion to avoid (or at least substantially reduce the likelihood that) a hematoma when they are expected.
- the patient may move around without being limited to a bed or chair.
- the garment also may enable the patient to carry on activities of daily living with minimal limitation. Accordingly, the garment may decrease the incidence of hematoma formation after cardiac device placement, especially when device implantation was done while the patient was on therapeutic anticoagulation.
- the garment may be used immediately after device implantation until the patient's anticoagulation levels settle to a prescribed therapeutic range. Also, the garment can compress a hematoma of the pocket that has already formed.
- the garment may reduce pain and suffering for the patient, decrease duration of hospitalization, decrease recurrent hospitalizations and additional interventions (e.g., reopening the device pocket and hematoma evacuations). Consequently, the garment potentially can reduce significant health care costs. Details of illustrative embodiments are discussed below.
- FIGS. 1 and 2 respectively show front and rear views of illustrative embodiments of a garment or vest 100 in a detached configuration. It should be noted that the specific dimensions in the drawing are exemplary only and thus, are not intended to limit various illustrative embodiments.
- FIGS. 6B and 6C schematically illustrate front and rear views, respectively, of a vest 100 worn by a patient.
- the vest 100 is a single structure configured to anchor over the patient's shoulder and wrap around (e.g., form a loop around) the patient's upper chest in a circumferential fashion.
- the vest 100 includes a waist band 110 configured to wrap around the patient's torso and secure the vest 100 to the patient.
- the waist band 110 includes a waist strap 220 coupled to a back flap 221 .
- the waist strap 220 includes a hook and loop patch 113 (e.g., Velcro) configured to removably and adjustably couple to a counterpart hook and loop patch 114 on a front flap 222 .
- the waist strap 220 may be useful in adjusting the top-to-bottom stretch and compression of the vest 100 .
- the vest 100 also includes left and right shoulder portions 101 and 105 extending from the waist band 110 .
- the left and right shoulder portions 101 and 105 are physically coupled by a shoulder strap 120 , to secure the vest 100 around the patient's shoulder.
- the strap 120 may go over the ipsilateral shoulder connecting the scapular portion 105 to the pectoral 101 portion of the vest.
- shoulder strap 120 and waist strap 220 provide stretch and compression of the vest 100 in four directions (e.g., left and right across the patient's torso, and up and down relative to the patient's shoulders).
- the vest 100 also includes at least one structure (e.g., 210 ; 211 ) for securing a compression block 700 (described below) to the vest 100 .
- the structure 210 ; 211 may be a pouch, or sealable pouch, to hold the compression block 700 .
- the structure 210 ; 211 may include straps, belts, hook and loop fasteners, or other devices.
- a pouch 210 holds the compression block 700 adjacent to an area on a patient's body where pressure is desired.
- the pouch 210 , 211 is on or in the inner surface 202 of the vest 100 , so that the vest 100 presses the block 700 towards the patient.
- Chest pads 103 and/or 104 hold a compression block 700 on the incision site ( 650 ) on patient's chest.
- chest pad 103 and/or 104 of the vest 100 may have a surface that is larger than their respective pouches 210 , 211 .
- the chest pads 103 and 104 provide a surface for applying a compressive force to the compression block 700 inside a pouch 210 , 211 .
- the amount of compressive force applied by chest pads 103 and 104 to the compression block 700 may be adjusted using a shoulder strap 120 and/or a waist strap 220 .
- Some embodiments may come pre-attached at the shoulder strap and can be worn around the shoulder like a sling. Such embodiments may omit the waist band 110 and its strap 220 .
- the vest 100 includes a stretchable body (e.g., waist strap 110 and/or shoulder portions 101 and 105 ) made up of stretchy or elastic materials, such as 2 mm thickness SBR Neoprene VELCRO compatible UBL finish, for example.
- stretchy or elastic materials such as 2 mm thickness SBR Neoprene VELCRO compatible UBL finish, for example.
- such materials may be waterproof and/or insulated.
- the outer surface 102 of the vest may be VELCRO compatible and the inner surface 101 may be smooth and impervious to water.
- FIG. 3B schematically illustrates a compression block 700 urged against a patient's body 350 by the stretchy material of a vest 100 .
- a bandage or dressing 355 is positioned between the compression block 700 and the patient 350 .
- tension in the material of the vest 100 imparts a force to the compression block 700 .
- the amount of the force may be adjusted by adjusting the straps 120 and/or 220 .
- the amount of the force may be a function of the elastic properties and/or tightness of the material of the vest 100 , in that the more the vest material is stretched, the greater the force it applies to the compression block 700 . As discussed below, this force produces a pressure to the patient's body 350 (e.g., a portion of the patient's torso).
- this pressure eventually aids in causing capillaries in the local area under pressure to coagulate, thus reducing and eventually stopping bleeding from the site.
- this pressure also preferably is low enough to mitigate the effect of a hematoma in that localized area. While a sufficiently high pressure is desired, such pressure also preferably is low enough to permit blood flow to the localized torso area. Accordingly, while reducing blood to the area to stop bleeding, blood still flows to the area to promote tissue health. As discussed below, a medical professional preferably can select the appropriate pressure to meet these competing demands.
- the amount, location and gradient of the applied force may influence the efficacy of the vest 100 .
- the compression applied by the compression block 700 is high immediately beneath the compression block 700 , but dissipates with distance from the block.
- the relatively high compression beneath the compression block 700 e.g., at point at point 361
- relatively lower compression away from the block e.g., at point 362
- the structure of the compression block 700 directly impacts efficacy.
- the inventors recognized that a solid compression block 700 produces a better-defined gradient than, for example, a bladder, which can be inflated. Accordingly, illustrative embodiments of the vest 100 and its compression block 700 should be beneficial to a patient with either or both a hematoma, and a high risk for pocket hematoma.
- FIG. 4 and FIG. 5 show that the fabric pad may be folded approximately at its middle.
- FIG. 6A , FIG. 6B and FIG. 6C schematically illustrate the patient with an incision 650 dressed on the left hand side of the body.
- FIG. 6B schematically illustrates a localized area 655 defined at least in part by the area where a compression block 700 meets a patient's body.
- FIG. 6B schematically illustrates a localized area 655 near a patient's incision 650 and suture 651 .
- FIG. 6C schematically shows a front view in an attached configuration on the patient
- FIG. 6D shows a rear view of the vest 100 in an attached configuration on the patient
- the apparatus may be dressed on the patient and may approximately look like the front view illustrated in FIG. 6C .
- the dressed apparatus may approximately look like the rear view illustration in FIG. 6D .
- the incision may be dressed on the right hand side of the body.
- the adjustments described in reference to FIG. 1 may also be made when the vest is on the patient.
- FIGS. 7A-7C schematically illustrate a compression block 700 in accordance with illustrative embodiments.
- the block 700 is solid, and in some embodiments is somewhat compressible. As a somewhat compressible member, the face of the block 700 preferably conforms to some extent with a facing surface of the portion of the patient to which it applies a pressure.
- the block 700 is not pneumatic, e.g., it is not an inflatable or deflatable bladder. Moreover, the block 700 is not formed from or include ice, which the inventors believe would be too hard and possibly injure the patient.
- the compression block 700 may be made of gel foam, polystyrene foam (e.g., STYROFOAM), or other appropriate material can be placed to enhance the compression/pressure applied to the local area, as described further below.
- a solid compression block provides advantages over a bladder.
- an inflatable bladder requires additional components, such as a pump mechanism to inflate the bladder, and a release mechanism to deflate the bladder.
- a pump mechanism to inflate the bladder
- a release mechanism to deflate the bladder.
- Such mechanisms increase the cost and complexity of the bladder, while decreasing the bladder's reliability and ease of use.
- a solid block 700 is simple, durable, and reliable.
- a bladder whether inflatable or otherwise deforms with an increase of internal pressure, and/or pressure against the patient, resulting a variable, and less precise pressure gradient and distribution or dispersal of pressure against the patient. Such an undesirable distribution of pressure can cause complications or impede the healing process.
- pressure applied by a block 700 is more readily focused on a desired area, with less distortion and uncertainty.
- a solid block 700 may provide a more effective pressure suited to patient comfort.
- the location of pressure applied to a patient by a solid block 700 results in part from the size of the surface of the block that faces the patient.
- embodiments of block 700 may have surfaces of varying shapes and sizes.
- the block 700 has a square or rectangular cross section, as schematically illustrated in FIG. 7E and FIG. 7F , respectively, while in other embodiments, the block 700 has a trapezoidal cross section as schematically illustrated in FIG. 7A .
- the top 701 of the block 700 may have the shape of the frustum of a pyramid.
- the height and length of the block 700 may be selected so as to cover the incision 650 and/or suture 651 .
- Illustrative embodiments of the block 700 have multiple surfaces, such as base surface 711 , and narrower top surface 701 .
- the localized area of pressure applied to the patient depends on which of those surfaces faces the patient.
- a surface of the block 700 to be positioned facing the patent may be determined by a user based on the size of the incision 650 , the suture 651 , and/or the size of the desired localized area 655 .
- the pressure applied to a patient by a solid block 700 results in part from the interaction of the block 700 with pliable nature of the material of a garment 100 .
- pressure applied to the localized area may be determined at least in part by the elasticity of the garment, the position of straps, and the surface area of the block.
- the pressure delivered to the patent depends in part on the force applied by the fabric, and the compressibility of the block 700 .
- the material selected for the compression block 700 may be foamed polystyrene.
- the block may be an arteriotomy pressure point pad available from Steri-Systems Corp., P.O. Box 909, 1314 Fourth Avenue, Auburn, Ga. 30011 (Mfg. SKU: 100W; National Stock Number (NSN) 6515-01-464-2574).
- the density of the foamed polystyrene may vary.
- material with 1 pound per cubic foot may be selected. However, preferred embodiments could vary density, such as from 0.5 to 1.5 pounds per cubic foot.
- the block 700 is non-compressible, or minimally compressible. If the block is too hard (e.g., steel; ice), the block 700 may fail to conform at all to the surface of the patient, and/or it may dig into the patient and distort the application of applied pressure.
- a minimally compressible block 700 may by a firm polystyrene material, or another material having a Young's modulus of between 2.0 ⁇ 10 ⁇ 10 dynes/cm 2 and 5.0 ⁇ 10 ⁇ 10 dynes/cm 2 , and may be a polystyrene having a Young's modulus of 3.43 ⁇ 10 ⁇ 10 dynes/cm 2 .
- the block 700 may have a Young's modulus similar to that of polystyrene at 3 to 3.5 GPa.
- the block 700 of some embodiments may have a Young's modulus similar to that of Dow Chemical Company's Styrofoam Highload 60 product has a vertical compressive strength of 60 psi (pounds per square inch), meaning that the product experiences 10% deformation under 60 psi of pressure.
- FIG. 7D schematically illustrates an embodiment that includes a filler block 730 configured to fit into a garment pouch, e.g., 210 , alongside a compression block 700 .
- a filler block 730 occupies space within the garment pouch 210 and forces the compression block 700 to one side or another of the garment pouch 210 , thereby allowing adjustment and fine-tuning of the position of the compression block 700 relative to the garment 100 , and relative to the localized area 655 .
- two or more filler blocks 730 may be used to position a compression block 700 within a pouch 210 .
- FIG. 8 schematically illustrates an alternative embodiment in which the garment 100 is in the form of a compression sleeve 800 .
- the sleeve 800 of this embodiment is configured to wrap around a patient's limb, such as an arm or leg, and to be secured in position by one or more straps 810 .
- the compression sleeve 800 includes a pouch 210 on an inner surface 801 for securing a compression block 700 between the inner surface 801 and the patient.
- the sleeve 800 includes a stretchy material to apply pressure to the compression block 700 , as described above in connection with the vest 100 .
- FIG. 9 is a flow chart illustrating a method of using a garment to selectively apply pressure to a localized area of a patient's body.
- the method may explain, for example, a method of mitigating pocket bleeding and hematoma formation in a patient.
- the process begins at step 900 , in which a medical professional or other user locates a localized area 655 of the patient's body (e.g., FIGS. 6A-6D ).
- the localized area 655 may be over a patient's incision 650 , or a suture 651 closing an incision in the patient's torso.
- the localized torso area has a topography, and may be at least in part covered by a bandage and/or dressing.
- step 902 secures a pliable wrap (i.e., the garment 100 ) around the torso of the patient as discussed above.
- the garment 100 is secured so that the block is aligned with the part of the patient's torso requiring pressure.
- the patient may have undergone surgery to receive an implantable device. Accordingly, the garment 100 is oriented so that the block is over at least a part of the patient's torso needing the pressure. At this point in the process, the block is between the patient's body (e.g., the bandage and/or dressing 355 ) and the wrap.
- the patient's body e.g., the bandage and/or dressing 355
- the wrap thus applies a force to the solid block, which produces a corresponding pressure on the localized torso area.
- This force is due to the cooperation of the material forming the wrap and straps, as well as the material properties of the block.
- the medical professional ensures that the force is neither too high nor too low.
- the force preferably is high enough to cause the pressure to hinder blood flow to the localized torso area. Accordingly, such a force should minimize or eventually stop bleeding at the local site.
- the pressure also preferably is low enough to cause the pressure to permit blood flow to the localized torso area.
- the force may be in a sufficient amount to cause the face of the block adjacent to the body to conform to some extent to the topography of at least a portion of the local region. This may further enhance the effect and controllability on hematomas and blood flow.
- a medical professional may check the progress of the localized torso area (step 903 ).
- the medical professional may remove the wrap to view the localized torso area after the prescribed time period. If the medical professional recognizes fluid discharge from the localized torso area, then the wrap may not have been secured with a sufficient force. In that case, the process continues to step 904 , in which the medical professional re-secures the wrap with a greater force than the force applied when initially secured. This greater force preferably is high enough to produce a greater block pressure to hinder blood flow to the localized torso area, but again, low enough to cause the pressure to permit blood flow to the localized torso area. Of course, when re-secured, the medical professional secures the wrap so that the block aligns with the local torso area being treated.
- the medical professional will re-secure the wrap in the same manner (i.e., aligning the block with the local area) at approximately the same force.
- the method illustrated by the flow chart in FIG. 9 is directed to a garment for use on a patient's torso, the method could also be applied to the use of garments on a patient's limb, such as sleeve 800 for example.
- the pressure that the garment applies is not sufficient to completely prevent blood flow. Rather, the garment applies a pressure sufficient to hinder but not completely prevent blood flow in the localized area 655 of the patient's body.
- VELCRO fasteners may be placed in different positions or switched, namely a felt fastener exchange for hook fastener and vice versa.
- any other appropriate attachment means including bonded pressure adhesives, now known or later devised, may also be equivalently substituted.
- no strap, tape, or other means may be necessary to secure the compression block to the vest 100 , the inclusion of such elements in some embodiments may be contemplated.
- Complementary VELCRO fasteners can also be provided on the outside ends of the waist band 110 so that waist band 110 can be stretched and overlapped at its opposing ends and thus connected together.
Abstract
Description
- Any and all applications for which a foreign or domestic priority claim is identified in the Application Data Sheet as filed with the present application are hereby incorporated by reference under 37 CFR 1.57.
- This patent application is a continuation of U.S. application Ser. No. 15/292,697, filed Oct. 13, 2016, entitled, “Cardiac Implantable Electronic Device Pocket Compression Apparatus and Method of Mitigating Localized Bleeding Using Same,” which claims priority from provisional U.S. patent application No. 62/240,967, filed Oct. 13, 2015, entitled, “Implantable Cardiac Device Pocket Compression Apparatus,” and naming Dhanunjaya Lakkireddy and Srijoy Mahapatra as inventors [practitioner's file 4179/1001], the disclosure of which is incorporated herein, in its entirety, by reference.
- The invention generally relates to a medical apparatus and, more particularly, the invention relates to a treatment apparatus for use in connection with cardiac device implantations.
- Several hundred thousands of patients receive subcutaneous cardiac devices (pacemakers, defibrillators, resynchronization therapy devices, loop recorders) throughout the world each year, with many thousands in the United States alone. With increasing advances in medical devices and the advent of life saving implantable cardioverter defibrillators along with cardiac resynchronization therapy, cardiac device therapy placed in the chest through the infraclavicular/subclavian approach has become very common. Usually, after sterile preparation, a small incision is made below the clavicle either on the right or left side. A subcutaneous pocket is created, bleeders are secured, and access to the subclavian vein or cephalic vein is obtained under the guidance of fluoroscopy. Then pacing or defibrillator leads may be placed in the appropriate chambers of the heart. These leads may be secured to the fascia over the pectoralis muscle and the end of which may be usually plugged into the ports in the device generator. The portion of the leads and the generator may be placed in the pocket and closed in two or three layers of suture. Bleeders may be secured before closing the pocket. Sterile strips may be placed over the closed incision and allowed to heal over the next few days.
- Based on prior research, pocket bleeding and hematoma formation may be seen in about 4.9% patients and the incidence may be higher in those receiving defibrillators compared to pacemakers. Pocket bleeding can prolong hospital stay in 1.5% of patients who receive these devices up to 2.5 days with about 0.5% requiring repeat hospitalization and close to 1% needing pocket revision and hematoma evacuation. The risk of post device bleeding and hematoma formation may be significantly higher (e.g., up to 12%-20%) in those patients who may be bridged with anticoagulants like heparin and enoxaparin. Even in those cases where warfarin is continued throughout the procedure, the risk of post procedural bleeding may be up to 2-6%. Often, large hematomas and subsequent evacuations lead to increased incidence of infection.
- Commonly, small swelling or hematoma left untreated and healing are left to normal body processes. However, hematomas and pocket bleeding can be serious enough in a certain percentage of patients as described above, requiring immediate attention. This can significantly increase the cost of treatment, and the amount of lost wages. This can also add a significant morbidity to the patient's health. Patients with device site hematomas and bleeding are at higher risk for infections which often require hospitalizations, intravenous antibiotic therapy and device extraction that leads to significant procedural risks, costs and patient comfort
- In accordance with one embodiment of the invention, a medical device for applying pressure to a localized area of patient's body includes a pliable wrap for wrapping around at least a portion of the patient, and a block of solid, non-inflatable material positioned between the wrap and the localized area of the patient. The wrap may be a vest for holding the block against the patient's torso, or a sleeve to hold the block against a patient's arm or a leg, to name but a few examples. In some embodiments, the wrap includes an elastic material, such as neoprene for example, and may also include straps to adjust the pressure applied to a localized area on the patient by the block.
- The block is sized and shaped to apply pressure to the localized area of the patient, which pressure is sufficient to hinder but not completely prevent blood flow in the localized area of the patient's body. For example, the block may have a wedge shape with a narrow face positioned to face the patient when the medical device is worn by the patient.
- Some embodiments include a sealable pouch in the medical device for securing the block in position, and some embodiments also include an absorbent sheath around the block within the pouch. Moreover, some embodiments include at least one filler member within the pouch to secure the location of the block within the pouch. Other embodiments secure the block with one or more straps, or a hook-and-loop fastener such as Velcro.
- In accordance with another embodiment of the invention, a method of mitigating pocket bleeding and hematoma formation in a patient locates a localized torso area of the patient that may be subject to bleeding and/or hematoma formation. The localized torso area is at least in part covered by a bandage and/or dressing. Next, the method provides a pliable wrap having a non-inflatable solid block coupled with the wrap, and then secures the pliable wrap around the torso of the patient to align the solid block with the located localized torso area. The solid block is secured between at least a portion of the wrap and the bandage and/or dressing, at least in part covering the localized torso area. The wrap is secured to cause the wrap to apply a force, to the solid block, that produces a corresponding pressure on the localized torso area. The force applied to the solid block is high enough to cause the pressure to hinder blood flow to the localized torso area to promote clotting at the localized torso area. At the same time, the force applied to the solid block is low enough to cause the pressure to permit blood flow to the localized torso area to promote healing.
- Those skilled in the art should more fully appreciate advantages of various embodiments from the following description discussed with reference to the drawings summarized immediately below.
-
FIG. 1 schematically illustrates a front view of the outer surface of a compression vest in a detached configuration in accordance with illustrative embodiments; -
FIG. 2 schematically illustrates a rear view of the inner surface of a compression vest in a detached configuration in accordance with illustrative embodiments; -
FIG. 3A schematically illustrates details of a fabric for a compression vest in accordance with illustrative embodiments; -
FIG. 3B schematically illustrates a compression block urged towards a patient's body by a garment; -
FIG. 3C schematically illustrates pressure gradient within a patient; -
FIG. 4 schematically illustrates a front view in an attached configuration in accordance with illustrative embodiments; -
FIG. 5 schematically shows a rear view in an attached configuration in accordance with illustrative embodiments; -
FIGS. 6A-6B schematically illustrate an incision on the chest of a patient; -
FIGS. 6C-6D schematically illustrate a front view in an attached configuration on a patient and a rear view in an attached configuration on a patient, respectively, in accordance with illustrative embodiments; -
FIGS. 7A-7D schematically illustrate embodiments of compression blocks for use with a compression garment in accordance with illustrative embodiments; -
FIGS. 7E-7F schematically illustrate cross sections of embodiments of compression blocks; -
FIG. 7G schematically illustrates an embodiment of a compression block in a sheath; -
FIG. 8 schematically illustrates an embodiment of a compression sleeve; -
FIG. 9 is a flow chart illustrating a method of using a garment. - Illustrative embodiments mitigate pocket bleeding and hematoma formation in a patient by providing constant, adjustable pressure to a localized area of the patient's body. To that end, a mechanical, noninvasive garment has adjustable levels of compression to treat and/or substantially reduce the likelihood of hematomas from cardiac devices, such as pacemakers, defibrillators, loop recorders, and pressure monitoring systems placed underneath the skin in the human chest/torso. Among other configurations, the garment may be formed as a single unit with straps, and includes a compression block in a pouch of the garment. During use, the block applies specific pressure to a targeted area of the patient. The garment may be worn in a similar manner to a jacket, i.e., over the shoulder that is closest to the cardiac device. A first shoulder strap can be adjusted for appropriate contact, while a second strap (e.g., around the chest) may be adjusted to selectively apply pressure to the block, consequently applying pressure to the targeted area. Illustrative embodiments may be used over a device pocket (formed in a patient's body), which may have a hematoma, or may be used in a prophylactic fashion to avoid (or at least substantially reduce the likelihood that) a hematoma when they are expected.
- During use, the patient may move around without being limited to a bed or chair. The garment also may enable the patient to carry on activities of daily living with minimal limitation. Accordingly, the garment may decrease the incidence of hematoma formation after cardiac device placement, especially when device implantation was done while the patient was on therapeutic anticoagulation. For patients on anticoagulants (e.g., heparin or enoxaparin), the garment may be used immediately after device implantation until the patient's anticoagulation levels settle to a prescribed therapeutic range. Also, the garment can compress a hematoma of the pocket that has already formed. As a result, the garment may reduce pain and suffering for the patient, decrease duration of hospitalization, decrease recurrent hospitalizations and additional interventions (e.g., reopening the device pocket and hematoma evacuations). Consequently, the garment potentially can reduce significant health care costs. Details of illustrative embodiments are discussed below.
-
FIGS. 1 and 2 respectively show front and rear views of illustrative embodiments of a garment orvest 100 in a detached configuration. It should be noted that the specific dimensions in the drawing are exemplary only and thus, are not intended to limit various illustrative embodiments.FIGS. 6B and 6C schematically illustrate front and rear views, respectively, of avest 100 worn by a patient. - The
vest 100 is a single structure configured to anchor over the patient's shoulder and wrap around (e.g., form a loop around) the patient's upper chest in a circumferential fashion. - The
vest 100 includes awaist band 110 configured to wrap around the patient's torso and secure thevest 100 to the patient. To that end, thewaist band 110 includes awaist strap 220 coupled to aback flap 221. Thewaist strap 220 includes a hook and loop patch 113 (e.g., Velcro) configured to removably and adjustably couple to a counterpart hook andloop patch 114 on afront flap 222. Thewaist strap 220 may be useful in adjusting the top-to-bottom stretch and compression of thevest 100. - The
vest 100 also includes left andright shoulder portions waist band 110. In use, when worn by a patient, the left andright shoulder portions shoulder strap 120, to secure thevest 100 around the patient's shoulder. For example, thestrap 120 may go over the ipsilateral shoulder connecting thescapular portion 105 to the pectoral 101 portion of the vest. - Together, the
shoulder strap 120 andwaist strap 220 provide stretch and compression of thevest 100 in four directions (e.g., left and right across the patient's torso, and up and down relative to the patient's shoulders). - The
vest 100 also includes at least one structure (e.g., 210; 211) for securing a compression block 700 (described below) to thevest 100. In illustrative embodiments, thestructure 210; 211 may be a pouch, or sealable pouch, to hold thecompression block 700. In some embodiments, thestructure 210; 211 may include straps, belts, hook and loop fasteners, or other devices. - More specifically, a
pouch 210 holds thecompression block 700 adjacent to an area on a patient's body where pressure is desired. In illustrative embodiments, thepouch inner surface 202 of thevest 100, so that thevest 100 presses theblock 700 towards the patient. -
Chest pads 103 and/or 104 hold acompression block 700 on the incision site (650) on patient's chest. In some embodiments,chest pad 103 and/or 104 of thevest 100 may have a surface that is larger than theirrespective pouches chest pads compression block 700 inside apouch chest pads compression block 700 may be adjusted using ashoulder strap 120 and/or awaist strap 220. - Some embodiments may come pre-attached at the shoulder strap and can be worn around the shoulder like a sling. Such embodiments may omit the
waist band 110 and itsstrap 220. - The
vest 100 includes a stretchable body (e.g.,waist strap 110 and/orshoulder portions 101 and 105) made up of stretchy or elastic materials, such as 2 mm thickness SBR Neoprene VELCRO compatible UBL finish, for example. In addition, as schematically illustrated inFIG. 3A , such materials may be waterproof and/or insulated. Moreover, theouter surface 102 of the vest may be VELCRO compatible and theinner surface 101 may be smooth and impervious to water. -
FIG. 3B schematically illustrates acompression block 700 urged against a patient'sbody 350 by the stretchy material of avest 100. In the embodiment ofFIG. 3B , a bandage or dressing 355 is positioned between thecompression block 700 and thepatient 350. When worn by a patient, tension in the material of thevest 100 imparts a force to thecompression block 700. The amount of the force may be adjusted by adjusting thestraps 120 and/or 220. In addition, the amount of the force may be a function of the elastic properties and/or tightness of the material of thevest 100, in that the more the vest material is stretched, the greater the force it applies to thecompression block 700. As discussed below, this force produces a pressure to the patient's body 350 (e.g., a portion of the patient's torso). - That force is high enough to cause the pressure to hinder blood flow to the localized torso area. Specifically, in illustrative embodiments, this pressure eventually aids in causing capillaries in the local area under pressure to coagulate, thus reducing and eventually stopping bleeding from the site. In addition, this pressure also preferably is low enough to mitigate the effect of a hematoma in that localized area. While a sufficiently high pressure is desired, such pressure also preferably is low enough to permit blood flow to the localized torso area. Accordingly, while reducing blood to the area to stop bleeding, blood still flows to the area to promote tissue health. As discussed below, a medical professional preferably can select the appropriate pressure to meet these competing demands.
- The amount, location and gradient of the applied force may influence the efficacy of the
vest 100. For example, as schematically by thecompression gradient line 360 illustrated inFIG. 3C , the compression applied by thecompression block 700 is high immediately beneath thecompression block 700, but dissipates with distance from the block. The relatively high compression beneath the compression block 700 (e.g., at point at point 361), and relatively lower compression away from the block (e.g., at point 362) forces fluids within a hematoma or pocket outward from under thecompression block 700. The structure of thecompression block 700 directly impacts efficacy. Specifically, the inventors recognized that asolid compression block 700 produces a better-defined gradient than, for example, a bladder, which can be inflated. Accordingly, illustrative embodiments of thevest 100 and itscompression block 700 should be beneficial to a patient with either or both a hematoma, and a high risk for pocket hematoma. - Specifically, various embodiments may be useful, for example, to:
- 1. Patients undergoing cardiac device implantation (pacemakers, cardioverter defibrillators, cardiac resynchronization therapy pacemakers & defibrillators, loop recorders, cardiac chamber pressure monitors) and chemotherapy ports who develop bleeding into the pocket and hematoma,
- 2. Patients who may be on antiplatelet and or anticoagulation therapy and may be at high risk for bleeding and hematoma formation,
- 3. Patients who may be on bridging therapy with heparin or enoxaparin immediately after cardiac device implantation for mechanical prosthetic valves, deep venous thrombosis, high risk atrial fibrillation patients, intracardiac thrombi etc.,
- 4. Patients who may be high risk for bleeding into pocket—elderly, renal failure, prolonged intervention, prior device extraction, pocket revisions, bleeding disorders etc., and/or
- 5. Patients who had a cardiac implantable electronic device (“CIED”) placed and developed a hematoma that needs that needs further care.
-
FIG. 4 andFIG. 5 show that the fabric pad may be folded approximately at its middle. -
FIG. 6A ,FIG. 6B andFIG. 6C schematically illustrate the patient with anincision 650 dressed on the left hand side of the body.FIG. 6B schematically illustrates alocalized area 655 defined at least in part by the area where acompression block 700 meets a patient's body. For example,FIG. 6B schematically illustrates alocalized area 655 near a patient'sincision 650 andsuture 651. -
FIG. 6C schematically shows a front view in an attached configuration on the patient, whileFIG. 6D shows a rear view of thevest 100 in an attached configuration on the patient. In some embodiments, from the front of the patient, the apparatus may be dressed on the patient and may approximately look like the front view illustrated inFIG. 6C . From the back of the patient, the dressed apparatus may approximately look like the rear view illustration inFIG. 6D . In other embodiments, the incision may be dressed on the right hand side of the body. In some embodiments, the adjustments described in reference toFIG. 1 may also be made when the vest is on the patient. -
FIGS. 7A-7C schematically illustrate acompression block 700 in accordance with illustrative embodiments. Theblock 700 is solid, and in some embodiments is somewhat compressible. As a somewhat compressible member, the face of theblock 700 preferably conforms to some extent with a facing surface of the portion of the patient to which it applies a pressure. Theblock 700 is not pneumatic, e.g., it is not an inflatable or deflatable bladder. Moreover, theblock 700 is not formed from or include ice, which the inventors believe would be too hard and possibly injure the patient. In some embodiments, thecompression block 700 may be made of gel foam, polystyrene foam (e.g., STYROFOAM), or other appropriate material can be placed to enhance the compression/pressure applied to the local area, as described further below. - The inventors have found that a solid compression block provides advantages over a bladder. For example, an inflatable bladder requires additional components, such as a pump mechanism to inflate the bladder, and a release mechanism to deflate the bladder. Such mechanisms increase the cost and complexity of the bladder, while decreasing the bladder's reliability and ease of use. In contrast, a
solid block 700 is simple, durable, and reliable. - Moreover, the inventors believe that a bladder (whether inflatable or otherwise) deforms with an increase of internal pressure, and/or pressure against the patient, resulting a variable, and less precise pressure gradient and distribution or dispersal of pressure against the patient. Such an undesirable distribution of pressure can cause complications or impede the healing process. In contrast, pressure applied by a
block 700 is more readily focused on a desired area, with less distortion and uncertainty. - As compared to a bladder, a
solid block 700 may provide a more effective pressure suited to patient comfort. - For example, the location of pressure applied to a patient by a
solid block 700 results in part from the size of the surface of the block that faces the patient. To that end, embodiments ofblock 700 may have surfaces of varying shapes and sizes. - In some embodiments, the
block 700 has a square or rectangular cross section, as schematically illustrated inFIG. 7E andFIG. 7F , respectively, while in other embodiments, theblock 700 has a trapezoidal cross section as schematically illustrated inFIG. 7A . For example, the top 701 of theblock 700 may have the shape of the frustum of a pyramid. The height and length of theblock 700 may be selected so as to cover theincision 650 and/orsuture 651. - Illustrative embodiments of the
block 700 have multiple surfaces, such asbase surface 711, and narrowertop surface 701. The localized area of pressure applied to the patient depends on which of those surfaces faces the patient. For example, a surface of theblock 700 to be positioned facing the patent may be determined by a user based on the size of theincision 650, thesuture 651, and/or the size of the desired localizedarea 655. - Further, in some embodiments, the pressure applied to a patient by a
solid block 700 results in part from the interaction of theblock 700 with pliable nature of the material of agarment 100. For example, pressure applied to the localized area may be determined at least in part by the elasticity of the garment, the position of straps, and the surface area of the block. In some embodiments, in which the material of the garment is elastic, the pressure delivered to the patent depends in part on the force applied by the fabric, and the compressibility of theblock 700. - In some embodiments, the material selected for the
compression block 700 may be foamed polystyrene. For example, the block may be an arteriotomy pressure point pad available from Steri-Systems Corp., P.O. Box 909, 1314 Fourth Avenue, Auburn, Ga. 30011 (Mfg. SKU: 100W; National Stock Number (NSN) 6515-01-464-2574). The density of the foamed polystyrene may vary. In preferred embodiments, material with 1 pound per cubic foot may be selected. However, preferred embodiments could vary density, such as from 0.5 to 1.5 pounds per cubic foot. - In some embodiments, the
block 700 is non-compressible, or minimally compressible. If the block is too hard (e.g., steel; ice), theblock 700 may fail to conform at all to the surface of the patient, and/or it may dig into the patient and distort the application of applied pressure. - To that end, in some embodiments, a minimally
compressible block 700 may by a firm polystyrene material, or another material having a Young's modulus of between 2.0×10−10 dynes/cm2 and 5.0×10−10 dynes/cm2, and may be a polystyrene having a Young's modulus of 3.43×10−10 dynes/cm2. In some embodiments, theblock 700 may have a Young's modulus similar to that of polystyrene at 3 to 3.5 GPa. As another example, theblock 700 of some embodiments may have a Young's modulus similar to that of Dow Chemical Company's Styrofoam Highload 60 product has a vertical compressive strength of 60 psi (pounds per square inch), meaning that the product experiences 10% deformation under 60 psi of pressure. -
FIG. 7D schematically illustrates an embodiment that includes afiller block 730 configured to fit into a garment pouch, e.g., 210, alongside acompression block 700. When placed in a garment pouch, e.g., 210, afiller block 730 occupies space within thegarment pouch 210 and forces thecompression block 700 to one side or another of thegarment pouch 210, thereby allowing adjustment and fine-tuning of the position of thecompression block 700 relative to thegarment 100, and relative to the localizedarea 655. In some embodiments, two or more filler blocks 730 may be used to position acompression block 700 within apouch 210. -
FIG. 8 schematically illustrates an alternative embodiment in which thegarment 100 is in the form of acompression sleeve 800. Thesleeve 800 of this embodiment is configured to wrap around a patient's limb, such as an arm or leg, and to be secured in position by one ormore straps 810. Thecompression sleeve 800 includes apouch 210 on aninner surface 801 for securing acompression block 700 between theinner surface 801 and the patient. In some embodiments, thesleeve 800 includes a stretchy material to apply pressure to thecompression block 700, as described above in connection with thevest 100. -
FIG. 9 is a flow chart illustrating a method of using a garment to selectively apply pressure to a localized area of a patient's body. The method may explain, for example, a method of mitigating pocket bleeding and hematoma formation in a patient. - The process begins at step 900, in which a medical professional or other user locates a
localized area 655 of the patient's body (e.g.,FIGS. 6A-6D ). For example, the localizedarea 655 may be over a patient'sincision 650, or asuture 651 closing an incision in the patient's torso. The localized torso area has a topography, and may be at least in part covered by a bandage and/or dressing. - Next,
step 902 secures a pliable wrap (i.e., the garment 100) around the torso of the patient as discussed above. To that end, thegarment 100 is secured so that the block is aligned with the part of the patient's torso requiring pressure. Among other things, as noted above, the patient may have undergone surgery to receive an implantable device. Accordingly, thegarment 100 is oriented so that the block is over at least a part of the patient's torso needing the pressure. At this point in the process, the block is between the patient's body (e.g., the bandage and/or dressing 355) and the wrap. - The wrap thus applies a force to the solid block, which produces a corresponding pressure on the localized torso area. This force is due to the cooperation of the material forming the wrap and straps, as well as the material properties of the block. The medical professional ensures that the force is neither too high nor too low. Specifically, the force preferably is high enough to cause the pressure to hinder blood flow to the localized torso area. Accordingly, such a force should minimize or eventually stop bleeding at the local site. Importantly, however, the pressure also preferably is low enough to cause the pressure to permit blood flow to the localized torso area. In some embodiments, the force may be in a sufficient amount to cause the face of the block adjacent to the body to conform to some extent to the topography of at least a portion of the local region. This may further enhance the effect and controllability on hematomas and blood flow.
- After the wrap has been secured for some prescribed amount of time (e.g., 30-90 minutes), a medical professional may check the progress of the localized torso area (step 903).
- To that end, the medical professional may remove the wrap to view the localized torso area after the prescribed time period. If the medical professional recognizes fluid discharge from the localized torso area, then the wrap may not have been secured with a sufficient force. In that case, the process continues to step 904, in which the medical professional re-secures the wrap with a greater force than the force applied when initially secured. This greater force preferably is high enough to produce a greater block pressure to hinder blood flow to the localized torso area, but again, low enough to cause the pressure to permit blood flow to the localized torso area. Of course, when re-secured, the medical professional secures the wrap so that the block aligns with the local torso area being treated.
- Alternatively, if in his/her professional judgement the local area is not bleeding/discharging fluid too much, then the medical professional will re-secure the wrap in the same manner (i.e., aligning the block with the local area) at approximately the same force.
- Although the method illustrated by the flow chart in
FIG. 9 is directed to a garment for use on a patient's torso, the method could also be applied to the use of garments on a patient's limb, such assleeve 800 for example. - The following is a listing of reference numbers used herein:
- 100: Compression vest
- 101: Left shoulder portion, or scapular end, of vest
- 102: Outer surface of vest
- 103: Left chest pad portion of vest
- 104: Right chest pad portion of vest
- 105: Right shoulder portion, or pectoral portion, of vest
- 110: Waist strap or main body of vest
- 112: Right end of waist strap
- 113: Velcro fastener
- 114: Opposing Velcro fastener
- 116: Left end of waist strap
- 202: Inner surface of vest
- 210: Left pouch
- 211: Right pouch
- 220: Waist strap
- 221: Back flap
- 222: Front flap
- 350: Surface of patient's body
- 355: Bandage or dressing
- 360: Gradient graph
- 361: Pressure point
- 362: Lesser pressure point
- 650: Incision site
- 651: Suture
- 655: Localized area
- 700: Compression block
- 701: Top of compression block
- 711: Bottom of compression block
- 730: Filler block
- 740: Sheath
- 800: Sleeve
- 801: Inner surface of sleeve
- 810: Sleeve straps
- Accordingly, unlike a tourniquet, when secured to the patient, the pressure that the garment applies is not sufficient to completely prevent blood flow. Rather, the garment applies a pressure sufficient to hinder but not completely prevent blood flow in the localized
area 655 of the patient's body. - It is expressly understood that many other embodiments and modifications may be contemplated as included within the apparatus although not specifically illustrated. For example, it may be expressly contemplated that VELCRO fasteners may be placed in different positions or switched, namely a felt fastener exchange for hook fastener and vice versa. In a similar manner, although VELCRO may be preferred attachment means, any other appropriate attachment means, including bonded pressure adhesives, now known or later devised, may also be equivalently substituted. Still further, although it may be expressly contemplated that no strap, tape, or other means may be necessary to secure the compression block to the
vest 100, the inclusion of such elements in some embodiments may be contemplated. - Complementary VELCRO fasteners can also be provided on the outside ends of the
waist band 110 so thatwaist band 110 can be stretched and overlapped at its opposing ends and thus connected together. - Although the above discussion discloses various exemplary embodiments, it should be apparent that those skilled in the art can make various modifications that may achieve some of the advantages of the embodiments described herein without departing from the true scope of the inventive concepts. All such variations and modifications are intended to be within the scope of the present inventions as defined in any appended claims.
Claims (11)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/940,133 US20200405321A1 (en) | 2015-10-13 | 2020-07-27 | Cardiac implantable electronic device pocket compression apparatus and method of mitigating localized bleeding using same |
US17/571,247 US20220125438A1 (en) | 2015-10-13 | 2022-01-07 | Cardiac implantable electronic device pocket compression apparatus and method of mitigating localized bleeding using same |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562240967P | 2015-10-13 | 2015-10-13 | |
US15/292,697 US10722244B2 (en) | 2015-10-13 | 2016-10-13 | Cardiac implantable electronic device pocket compression apparatus and method of mitigating localized bleeding using same |
US16/940,133 US20200405321A1 (en) | 2015-10-13 | 2020-07-27 | Cardiac implantable electronic device pocket compression apparatus and method of mitigating localized bleeding using same |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/292,697 Division US10722244B2 (en) | 2015-10-13 | 2016-10-13 | Cardiac implantable electronic device pocket compression apparatus and method of mitigating localized bleeding using same |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/571,247 Continuation-In-Part US20220125438A1 (en) | 2015-10-13 | 2022-01-07 | Cardiac implantable electronic device pocket compression apparatus and method of mitigating localized bleeding using same |
Publications (1)
Publication Number | Publication Date |
---|---|
US20200405321A1 true US20200405321A1 (en) | 2020-12-31 |
Family
ID=58499171
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/292,697 Active 2037-03-05 US10722244B2 (en) | 2015-10-13 | 2016-10-13 | Cardiac implantable electronic device pocket compression apparatus and method of mitigating localized bleeding using same |
US16/940,133 Pending US20200405321A1 (en) | 2015-10-13 | 2020-07-27 | Cardiac implantable electronic device pocket compression apparatus and method of mitigating localized bleeding using same |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/292,697 Active 2037-03-05 US10722244B2 (en) | 2015-10-13 | 2016-10-13 | Cardiac implantable electronic device pocket compression apparatus and method of mitigating localized bleeding using same |
Country Status (3)
Country | Link |
---|---|
US (2) | US10722244B2 (en) |
EP (1) | EP3361963A4 (en) |
WO (1) | WO2017066430A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USD966529S1 (en) | 2019-09-30 | 2022-10-11 | L&M Innovations LLC | Compression apparatus |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9775971B2 (en) * | 2014-03-04 | 2017-10-03 | Patches Duana Hidalgo | Wraps |
USD810951S1 (en) * | 2016-02-17 | 2018-02-20 | Tookie Limited | Medical vest |
USD859667S1 (en) * | 2016-12-23 | 2019-09-10 | John Mötteli | Mask |
USD858780S1 (en) * | 2018-11-19 | 2019-09-03 | Muhammad Sikandar | Posture brace with belt holder |
USD903882S1 (en) * | 2019-02-18 | 2020-12-01 | Michael Bucknell | Support brace |
Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4005709A (en) * | 1975-04-11 | 1977-02-01 | Laerdal A S | Compression bandage |
US4182338A (en) * | 1977-12-29 | 1980-01-08 | Smyth County Dialysis Unit | Pressure applying device |
US5514155A (en) * | 1993-12-14 | 1996-05-07 | Daneshvar; Yousef | Device for applying pressure to a person's groin |
US5891070A (en) * | 1995-11-09 | 1999-04-06 | Sumitomo Rubber Industries, Ltd. | Breast presser belt |
US6274786B1 (en) * | 1998-04-27 | 2001-08-14 | Brian Heller | Anti-reflux/heartburn device |
US20030176828A1 (en) * | 2002-02-04 | 2003-09-18 | Damage Control Surgical Technologies, Inc. | Method and apparatus for improved hemostasis and damage control operations |
US20050182344A1 (en) * | 2004-02-17 | 2005-08-18 | Pamela Dixon | Recovery belt apparatus |
US20080188788A1 (en) * | 2006-10-25 | 2008-08-07 | Serola D C Richard J | Compression Wrap |
US20080319473A1 (en) * | 2007-06-20 | 2008-12-25 | Murray Rosenbaum | Device for applying pressure to a pocket to prevent hematoma after surgical implantation of medical device and method of using the same |
WO2009017442A1 (en) * | 2007-07-27 | 2009-02-05 | Otto Bock Scandinavia Ab | Shoulder orthosis |
US20100179586A1 (en) * | 2007-06-01 | 2010-07-15 | Ward Kevin R | Device For Control of Difficult to Compress Hemorrhage |
US20110077573A1 (en) * | 2009-09-28 | 2011-03-31 | Karen Pain | Protective Wraps and Methods of Animal Wound Care |
US20150305958A1 (en) * | 2014-04-25 | 2015-10-29 | Medtronic Vascular, Inc. | Tissue Compression Device with Fixation and Tension Straps |
US10179075B1 (en) * | 2010-04-07 | 2019-01-15 | Shawn Hickling | Shoulder thermal therapy wrap |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5235975A (en) * | 1992-01-13 | 1993-08-17 | Pressure Products Medical Supplies, Inc. | Cardiac pacemaker compression harness |
US5843008A (en) * | 1996-12-10 | 1998-12-01 | Gerhard; Harvey | Method for mitigating pain when coughing following surgery |
GB9720292D0 (en) | 1997-09-24 | 1997-11-26 | Bcb Limited | Medical support |
US6155996A (en) | 1998-06-30 | 2000-12-05 | American Biosystems, Inc. | Disposable pneumatic chest compression vest |
US7943810B2 (en) * | 2003-02-04 | 2011-05-17 | Buckman Robert F | Method and apparatus for hemostasis |
US7316658B2 (en) | 2003-09-08 | 2008-01-08 | Hill-Rom Services, Inc. | Single patient use vest |
US8430830B1 (en) * | 2008-10-14 | 2013-04-30 | Alfredo Ernesto Hoyos Ariza | Post operative pressure garment |
US20100228171A1 (en) | 2009-03-04 | 2010-09-09 | Waldridge Irene A | Therapeutic compression garment |
US8926536B2 (en) | 2009-08-07 | 2015-01-06 | The Seaberg Company, Inc. | Device and method for control of hemorrhage |
CN202051904U (en) * | 2011-03-29 | 2011-11-30 | 华中科技大学同济医学院附属同济医院 | Medical armpit compression tape |
US20130085427A1 (en) | 2011-09-29 | 2013-04-04 | Tyco Healthcare Group Lp | Compression garment having sealable bladder pocket |
WO2013163259A2 (en) | 2012-04-25 | 2013-10-31 | University Of Delaware | Supercapacitor electrodes and associated methods of manufacturing |
CN202722580U (en) * | 2012-05-30 | 2013-02-13 | 上海市奉贤区中心医院 | Protective clothing used after cardiac pacemaker cathelerization |
US9642559B2 (en) | 2012-10-11 | 2017-05-09 | Medline Industries, Inc. | Compression device with sizing indicia |
US20150073317A1 (en) * | 2013-09-10 | 2015-03-12 | Wesley Cox | Device and method for applying pressure to a mammalian limb |
WO2016001802A1 (en) | 2014-07-01 | 2016-01-07 | Angeloro Ciro | Medical apparatus for the containment of haematomas |
US9789006B2 (en) * | 2014-10-02 | 2017-10-17 | Cardiac Ep Education And Innovation, Llc | Pressure bandage |
-
2016
- 2016-10-13 WO PCT/US2016/056813 patent/WO2017066430A1/en active Application Filing
- 2016-10-13 US US15/292,697 patent/US10722244B2/en active Active
- 2016-10-13 EP EP16856179.3A patent/EP3361963A4/en not_active Withdrawn
-
2020
- 2020-07-27 US US16/940,133 patent/US20200405321A1/en active Pending
Patent Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4005709A (en) * | 1975-04-11 | 1977-02-01 | Laerdal A S | Compression bandage |
US4182338A (en) * | 1977-12-29 | 1980-01-08 | Smyth County Dialysis Unit | Pressure applying device |
US5514155A (en) * | 1993-12-14 | 1996-05-07 | Daneshvar; Yousef | Device for applying pressure to a person's groin |
US5891070A (en) * | 1995-11-09 | 1999-04-06 | Sumitomo Rubber Industries, Ltd. | Breast presser belt |
US6274786B1 (en) * | 1998-04-27 | 2001-08-14 | Brian Heller | Anti-reflux/heartburn device |
US20030176828A1 (en) * | 2002-02-04 | 2003-09-18 | Damage Control Surgical Technologies, Inc. | Method and apparatus for improved hemostasis and damage control operations |
US20050182344A1 (en) * | 2004-02-17 | 2005-08-18 | Pamela Dixon | Recovery belt apparatus |
US20080188788A1 (en) * | 2006-10-25 | 2008-08-07 | Serola D C Richard J | Compression Wrap |
US20100179586A1 (en) * | 2007-06-01 | 2010-07-15 | Ward Kevin R | Device For Control of Difficult to Compress Hemorrhage |
US20080319473A1 (en) * | 2007-06-20 | 2008-12-25 | Murray Rosenbaum | Device for applying pressure to a pocket to prevent hematoma after surgical implantation of medical device and method of using the same |
WO2009017442A1 (en) * | 2007-07-27 | 2009-02-05 | Otto Bock Scandinavia Ab | Shoulder orthosis |
US20110077573A1 (en) * | 2009-09-28 | 2011-03-31 | Karen Pain | Protective Wraps and Methods of Animal Wound Care |
US10179075B1 (en) * | 2010-04-07 | 2019-01-15 | Shawn Hickling | Shoulder thermal therapy wrap |
US20150305958A1 (en) * | 2014-04-25 | 2015-10-29 | Medtronic Vascular, Inc. | Tissue Compression Device with Fixation and Tension Straps |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USD966529S1 (en) | 2019-09-30 | 2022-10-11 | L&M Innovations LLC | Compression apparatus |
Also Published As
Publication number | Publication date |
---|---|
WO2017066430A1 (en) | 2017-04-20 |
US10722244B2 (en) | 2020-07-28 |
EP3361963A1 (en) | 2018-08-22 |
EP3361963A4 (en) | 2019-07-10 |
US20170100130A1 (en) | 2017-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20200405321A1 (en) | Cardiac implantable electronic device pocket compression apparatus and method of mitigating localized bleeding using same | |
US7559908B2 (en) | Compression apparatus for applying localized pressure to a wound or ulcer | |
EP2077102B1 (en) | Positive pressure chamber for extremities | |
US9033906B2 (en) | Therapeutic compression apparatus | |
US7637923B2 (en) | Method and apparatus for facilitating the healing of bone fractures | |
US20080178390A1 (en) | Thigh support with free space for popliteal fossa | |
US6516804B1 (en) | Cardio-thoracic compression harness | |
US9789006B2 (en) | Pressure bandage | |
US20030009120A1 (en) | Device for prevention of abnormal joint rotation | |
US6283124B1 (en) | Versatile compression garment | |
US5235975A (en) | Cardiac pacemaker compression harness | |
US6540702B1 (en) | Breast compressing device | |
US20220125438A1 (en) | Cardiac implantable electronic device pocket compression apparatus and method of mitigating localized bleeding using same | |
US8506509B1 (en) | Post operative pressure garment | |
CN207949855U (en) | A kind of postoperative pressure fixing belt of Pacemaker implantation | |
US20220387249A1 (en) | Therapeutic compression apparatus, system and methods of use | |
US20150209218A1 (en) | Cardiac pacemaker and defribrillator compression pad | |
CN208492437U (en) | A kind of anti-torsion shoes of lower limb bone surgery | |
KR102105406B1 (en) | Tourniquet and hemostatic method using the same | |
CN203710068U (en) | Compression-hemostasis fixing device at implanting part of permanent pacemaker | |
JP2014054467A (en) | Compression band used after device implantation operation | |
US20170156735A1 (en) | Incision compression device | |
CN220090269U (en) | Braces formula pacemaker fixing device | |
CN207693874U (en) | Inflate electrotherapy formula ankle-joint care device | |
US20220265455A1 (en) | Improved medical apparatus for containing haematomas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |